NewAmsterdam Pharma Company NAMS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by NewAmsterdam Pharma Company in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's operating lease ROU assets?
- NewAmsterdam Pharma Company (NAMS) reported operating lease ROU assets of $21K in Q1 2026.
- How has NewAmsterdam Pharma Company's operating lease ROU assets changed year-over-year?
- NewAmsterdam Pharma Company's operating lease ROU assets decreased by 94.3% year-over-year, from $369K to $21K.
- What is the long-term trend for NewAmsterdam Pharma Company's operating lease ROU assets?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's operating lease ROU assets has grown at a 15.5% compound annual growth rate (CAGR), from $120K to $185K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.